January 2026 brought major GLP-1 updates, from the launch of the first oral Wegovy pill to a new federal insurance model that contrasts sharply with growing state-level restrictions. This roundup synthesizes the key clinical and regulatory news, providing practice-focused takeaways on what providers need to know about the evolving landscape.
We know starting a new aesthetics practice or medspa can be scary, especially if you’re new to the field!
That’s why we’ve put together this helpful guide to take you through some of the important points of starting your new practice.
Is weight regain inevitable after you stop taking GLP‑1 drugs like Ozempic or Wegovy? This article explains why most people regain, what the “keep it off” group does differently, and how holistic programs like Clean Start Weight Loss® can help you plan for life beyond injections.
Discover 5 hidden GLP-1 side effects linked to malnutrition—from chills to hair loss. Learn warning signs, timelines, and why comprehensive lifestyle support is essential for safe weight loss.
The World Health Organization’s endorsement of GLP-1 therapies for obesity treatment adds significant global validation to what providers already know: medical weight management continues to evolve with new clinical data, expanded treatment options, and refined care models. This update summarizes the four most clinically relevant developments shaping your practice and patient outcomes.
In order to have a successful aesthetic practice, you need to have effective advertising to attract people to your business.
This includes spending those marketing dollars effectively and having a team of staff that are well informed.
In order to have a successful aesthetic practice, you need to have effective advertising to attract people to your business.
This includes spending those marketing dollars effectively and having a team of staff that are well informed.
The FDA has approved the first oral GLP-1 pill for weight loss, delivering comparable efficacy to injectable formulations while addressing patient concerns about needles and cost. For aesthetic medicine practitioners, understanding this new GLP-1 treatment option is essential for informed patient conversations about weight management.
A 3‑hour, CME‑accredited GLP‑1 Essentials course designed for Arizona family physicians and NPs who want to offer safe, evidence‑based medical weight loss. Learn practical semaglutide and tirzepatide protocols online, then choose to deepen your skills with in‑person CWMP training in Scottsdale.
The WHO’s endorsement of GLP-1s for obesity marks a pivotal moment in medical weight management. Discover strategies to differentiate your practice and thrive in this evolving landscape.